WASHINGTON, Jan 5 (Reuters) - The U.S. Food and Drug Administration and GlaxoSmithKline Plc have warned doctors about new or worsening eye complications in patients taking three of its diabetes drugs, according to a letter made public on Thursday.
WASHINGTON, Jan 5 (Reuters) - The U.S. Food and Drug Administration and GlaxoSmithKline Plc have warned doctors about new or worsening eye complications in patients taking three of its diabetes drugs, according to a letter made public on Thursday.
